7 sources checked · 2 source groups included · 25m ago
Still Watching
FDA approves landmark pancreatic cancer drug that's shown to improve survival
Headlines vary in describing the new pancreatic cancer drug, using terms like "landmark," "first-of-a-kind," or "breakthrough," with one localizing the trial.
1 Left6 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 26, 2026 at 11:09 PM, this is how Optics News reads the wording differences in this story.
What happenedThe drug uses a new approach to block a protein that fuels tumor growth. Patients taking the drug nearly doubled their survival time in a company study.
The headline splitThe left frames it as "FDA approves landmark pancreatic cancer drug that's shown to improve survival". The center frames it as "Groundbreaking pancreatic cancer drug approved by FDA".
Match confidenceMedium confidence. 7 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
7 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
65/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA approves landmark pancreatic cancer drug that's shown to improve survival
ABC News - Business · Center-left · News report
CenterFDA approves landmark pancreatic cancer drug that's shown to improve survival
WBIR10 (Tegna, Knoxville) · Center · News report
Right / center-rightNo matching source in this bucket yet.
FDA approves landmark pancreatic cancer drug that's shown to improve survival
landmarkimprove survival
The drug uses a new approach to block a protein that fuels tumor growth. Patients taking the drug nearly doubled their survival time in a company study.
FDA approves new drug Rasonque to treat advanced pancreatic cancer
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the...
FDA approves first-of-a-kind pancreatic cancer drug trialed in Boston
first-of-a-kindtrialed in Boston
A first-of-a-kind pancreatic cancer drug given approval by the FDA on Wednesday was trialed at Dana-Farber in Boston. It offers a new approach to treating the deadly form of cancer.
Groundbreaking pancreatic cancer drug approved by FDA
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms...
